Chronic pancreatitis represents a prevalent risk factor for the development of pancreatic cancer, thus necessitating more scrutiny of the association between GLP-1R agonists and the induction of chronic pancreatitis [67,68]. The gene discussed is GLP1R; the disease is familial pancreatic carcinoma.